Commentary by Dr Kenichi Sakakura

Commentary by Dr Milind Desai

Commentary by Dr Jia-Ling Lin

Commentary by Dr. Sadeer Al-Kindi and Dr. Carrie R. Howell

Commentary by Ratika Parkash

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides and Dr. Ashok Krishnaswami

Commentary by Dr. Candice Silversides and Dr. Kamala Tamirisa

Commentary by Dr. Candice Silversides, Dr. Emily Lau, and Dr. Nandita Scott

Alexander Fanaroff, MD, MHS discusses how behavioral economic principles can be used to incentivize healthy behaviors in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.